

NEW BRUNSWICK, N.J., June 25 (UPI) -- An official with Massachusetts headquartered Abiomed Inc. says the company's new artificial heart has been successfully implanted in a patient.
Abiomed chief executive Michael R. Minogue said the first commercial implantation of the AbioCor device took place at Robert Wood Johnson University Hospital in New Brunswick, N.J., The Boston Globe said Thursday.
"It's a great milestone for the company," Minogue said of the June 15 procedure.
The AbioCor was approved for commercial use by the U.S. Food and Drug Administration in 2006, but transplants must be limited to patients unable to receive normal heart transplants.
Minogue said the AbioCor, whose earlier version was used in 14 transplant procedures as part of clinical trials, represents more of a technological advance by the company than a high revenue product.
"It's a sign of our technology expertise. No other company makes a completely self-contained implantable artificial heart," he said of the product, which is made of titanium and plastic. "But what we're really focused on is heart recovery and helping people support the heart.''
|
|
|
| Additional Science News Stories | |
CAMBRIDGE, Ohio, Feb. 9 (UPI) --
An Ohio father was charged Thursday with felony domestic violence for allegedly putting his 3-year-old son in a clothes dryer and turning it on.
|
NEW YORK, Feb. 9 (UPI) --
Macaulay Culkin is in "perfectly good health," his publicist said after the former child star was photographed looking gaunt and disheveled in New York.
|
GREENBELT, Md., Feb. 9 (UPI) --
NASA's Mars Reconnaissance Orbiter has captured the first color image from orbit of the three-petal lander of NASA's 2004 Rover Spirit mission, scientists say.
|
UPI horoscopes for Friday, Feb. 10, 2012.
|
| Stories | Photos | People | Comments |
View Caption